For additional information on these trials, please contact Dr. Kelly Hume or Dr. Cheryl Balkman of the Cornell University Hospital for Animals Oncology Service at 607-253-3060.
More Clinical Trials
For more clinical trials opportunities, visit the Veterinary Medicine Clinical Trials website,
or contact the Clinical Research Coordinator at:
Kelly R. Hume
College of Veterinary Medicine
C3501C CPC, Box 31
Ithaca, NY 14853
P (607) 253-3516
F (607) 253-3055
Clinical Trials for Dr. Kelly Hume
TRIALS FOR CATS
Study title: Individualized dosing of carboplatin in cats with injection site sarcomas
- Inclusion criteria: Cats with histological confirmation of tumor type and a measurable primary tumor or metastatic lesion.
- Purpose: Determine the response rate and toxicity of carboplatin treatment (dosage based on GFR) in cats with injection site sarcomas. It is hypothesized that individualized dosing of carboplatin based on kidney function will be effective and well tolerated.
- Benefit: Study pays for cost of GFR, two carboplatin treatments, and CBC monitoring after treatment.